The U.S. Food and Drug Administration on Friday authorized the Pfizer Inc (PFE.N) and BioNTech SE coronavirus vaccine for children aged 5 to 11 years, making it the first COVID-19 shot for young children in the United States.
The shot will not be immediately available to the age group. The U.S. Centers for Disease Control and Prevention still need to make recommendations on how the shot should be administered, which will be decided after a group of outside advisers discuss the plans on Tuesday.
Pfizer said it will begin shipping pediatric vials of the vaccine on Saturday to pharmacies, pediatricians’ offices and other places where the shots may be administered.
The FDA decision is expected to make the shot available to 28 million American children, many of whom are back in school for in-person learning.
Source: Jordan News Agency